Form 4: Adaptive Biotechnologies Director Exercises Stock Options
SEC Form 4
Director Peter M Neupert exercised stock options to acquire 15,000 shares of Adaptive Biotechnologies Corp at $0.84 per share on March 12, 2024.
Summary
- On March 12, 2024, Peter M Neupert, a director of Adaptive Biotechnologies Corp, exercised stock options.
- This transaction involved the acquisition of 15,000 shares of common stock at a price of $0.84 per share.
- Following the transaction, Neupert directly owns 169,296 shares of Adaptive Biotechnologies Corp.
- The stock option was fully vested as of January 1, 2015.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| January 1, 2015 | The stock option was fully vested. |
| 03/12/2024 | Peter M Neupert exercised stock options to acquire 15,000 shares. |
| 03/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.